CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a highly progressive and debilitating neurodegenerative disease, which usually leads to the death of affected individuals within a few years after the onset of symptoms. ALS is currently incurable and very little is known about its pathophysiology....

Descripción completa

Detalles Bibliográficos
Autores principales: Agah, Elmira, Saleh, Fatemeh, Sanjari Moghaddam, Hossein, Saghazadeh, Amene, Tafakhori, Abbas, Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300914/
https://www.ncbi.nlm.nih.gov/pubmed/30572951
http://dx.doi.org/10.1186/s13643-018-0913-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300914/
https://www.ncbi.nlm.nih.gov/pubmed/30572951
http://dx.doi.org/10.1186/s13643-018-0913-4

Ejemplares similares